What are the causes of lymphocytosis (high lymphocytes)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Lymphocytosis (High Lymphocytes)

Lymphocytosis is most commonly caused by infections (particularly viral), but can also result from malignancies, autoimmune disorders, medications, and stress responses. The underlying causes can be broadly categorized into reactive (benign) and malignant etiologies.

Reactive (Benign) Causes

Viral Infections

  • Epstein-Barr virus (infectious mononucleosis)
  • Cytomegalovirus (CMV)
  • HIV
  • Hepatitis viruses
  • Other viral infections

Bacterial Infections

  • Certain bacterial infections can trigger lymphocytosis
  • Particularly those causing prolonged immune stimulation

Autoimmune Disorders

  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Other autoimmune conditions 1

Medications

  • Corticosteroids
  • Lithium
  • Beta agonists 2

Stress Responses

  • Physical stress (seizures, anesthesia, overexertion)
  • Emotional stress 2

Other Reactive Causes

  • Post-splenectomy state
  • Smoking
  • Hypersensitivity reactions

Malignant Causes

Lymphoproliferative Disorders

  • Chronic lymphocytic leukemia (CLL) - most common cause of persistent lymphocytosis in adults 3
  • Lymphomas (particularly T-cell and NK-cell lymphomas)
  • Acute lymphoblastic leukemia

Myeloproliferative Disorders

  • Can occasionally present with lymphocytosis 2

Hemophagocytic Lymphohistiocytosis (HLH)

  • Can be associated with:
    • T-cell and NK-cell lymphomas/leukemias
    • Diffuse large B-cell lymphoma (DLBCL)
    • Hodgkin lymphoma 4
  • Often triggered by viral infections, particularly EBV-associated lymphomas 4

Diagnostic Approach

Initial Assessment

  • Complete blood count with differential
  • Peripheral blood smear examination
    • Presence of abnormal cells (blasts, lymphoma cells) suggests malignancy
    • Reactive lymphocytes (larger, more cytoplasm, irregular nuclei) suggest viral infection 5

Risk Factors for Malignancy

  • Age (risk increases with age) 4
  • Persistent lymphocytosis without explanation
  • Concurrent abnormalities in red blood cell or platelet counts
  • Weight loss, bleeding/bruising
  • Hepatosplenomegaly or lymphadenopathy 2

Warning Signs

  • White blood cell counts above 100,000/mm³ represent a medical emergency due to risk of brain infarction and hemorrhage 2
  • Monomorphic appearance of lymphocytes suggests malignancy
  • Pleomorphic lymphocytes suggest reactive causes 5

Special Considerations

Chronic Lymphocytic Leukemia

  • Most patients present incidentally due to lymphocytosis found on routine blood tests
  • Outcomes vary based on genetic predisposition and prognostic markers (age, staging, B2-microglobulin) 3
  • Patients with CLL have increased risk of major infections, secondary cancers, and autoimmune diseases 6

Distinguishing Features

  • Malignant lymphocytosis: monoclonal population, abnormal morphology, persistent elevation
  • Reactive lymphocytosis: polyclonal, normal or atypical morphology, usually transient

Common Pitfalls

  • Assuming all lymphocytosis is benign in the absence of symptoms
  • Failing to follow up on persistent lymphocytosis
  • Not considering medication effects when evaluating lymphocytosis
  • Missing the diagnosis of CLL, which often presents asymptomatically with isolated lymphocytosis

When evaluating lymphocytosis, the clinical context, duration, degree of elevation, and morphologic features of the lymphocytes are crucial in determining whether the cause is benign or malignant.

References

Research

Nonmalignant disorders of lymphocytes.

Clinical laboratory science : journal of the American Society for Medical Technology, 1997

Research

Leukocytosis: basics of clinical assessment.

American family physician, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Malignant or benign hyperleukocytosis ?].

Revue medicale de Bruxelles, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.